West Pharmaceutical Services (WST) Current Leases (2019 - 2026)

West Pharmaceutical Services has disclosed Current Leases across 8 years of filings, most recently posting $21.4 million for Q1 2026.

• Current Leases for Q1 2026 came in at $21.4 million, down 1.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.4 million (down 1.83% YoY), and the FY2025 annual result was $22.7 million, up 26.82% from the prior year.
• Current Leases came in at $21.4 million for Q1 2026 at West Pharmaceutical Services, down from $22.7 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $22.7 million in Q4 2025 to a low of $9.8 million in Q1 2022.
• The 5-year median for Current Leases is $17.9 million (2024), against an average of $17.7 million.
• Across the five-year window, Current Leases jumped 72.04% in 2022 and declined 1.83% in 2026, its largest moves.
• West Pharmaceutical Services' Current Leases stood at $16.0 million in 2022, then rose by 10.62% to $17.7 million in 2023, then grew by 1.13% to $17.9 million in 2024, then climbed by 26.82% to $22.7 million in 2025, then declined by 5.73% to $21.4 million in 2026.
• The last three Current Leases figures came in at $21.4 million (Q1 2026), $22.7 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.